Novartis suspends two cancer therapies over quality concerns
ZURICH, May 5 (Reuters) - Novartis said on Thursday it had temporarily suspended the production of its Lutathera and Pluvicto cancer therapies at...
ZURICH, May 5 (Reuters) - Novartis said on Thursday it had temporarily suspended the production of its Lutathera and Pluvicto cancer therapies at...